EnteroMedics Inc.
ETRM
ETRM was delisted on the 20th of October, 2017.
46 hedge funds and large institutions have $22.3M invested in EnteroMedics Inc. in 2014 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 10 closing their positions.
49% more call options, than puts
Call options by funds: $225K | Put options by funds: $151K
13% more capital invested
Capital invested by funds: $19.8M → $22.3M (+$2.53M)
6% less funds holding
Funds holding: 49 → 46 (-3)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$494K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$189K |
| 3 |
IHM
Iguana Healthcare Management
New York
|
+$130K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$37.8K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$36.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$798K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$161K |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
-$143K |
| 4 |
HLA
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
-$136K |
| 5 |
Goldman Sachs
New York
|
-$109K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PRCM
51
Pine River Capital Management
Minnetonka,
Minnesota
| – | -$1K | -11 | Closed |
|
52
Citadel Advisors
Miami,
Florida
| – | -$7K | -5 | Closed |
|
|
TRCT
53
Tower Research Capital (TRC)
New York
| – | -$4K | -3 | Closed |
|
|
PFO
54
Pathstone Family Office
Englewood,
New Jersey
| – | -$3K | -2 | Closed |
|
55
Ameriprise
Minneapolis,
Minnesota
| – | -$2K | -1 | Closed |
|
56
Citigroup
New York
| – | -$1K | -1 | Closed |
|
ETRM Hedge Fund Activity: Q4 2014 in Review
46 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q4 2014, worth a combined $22.3M — up 13% from $19.8M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ETRM and 8 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 6 added.
The largest buyer was Fred Alger Management, adding an estimated $494K. The largest seller was Royce & Associates, exiting entirely with an estimated $798K sold.
- 46 institutional investors held EnteroMedics Inc. (ETRM) as of Q4 2014, down from 49 in Q3 2014.
- Funds reported $22.3M of EnteroMedics Inc. stock for Q4 2014, up 13% quarter-over-quarter.
- 8 funds opened new EnteroMedics Inc. positions in Q4 2014 and 10 closed out, a net change of -2 holders.
- The largest EnteroMedics Inc. buyer in Q4 2014 was Fred Alger Management, an estimated $494K added.
- The largest EnteroMedics Inc. seller in Q4 2014 was Royce & Associates, an estimated $798K sold.
Based on aggregated 13F filings for Q4 2014.